| Literature DB >> 33785077 |
Nathalie Swinnen1,2, Mathieu Vandenbulcke2,3, Eling D de Bruin4,5, Riekje Akkerman6, Brendon Stubbs7,8, Joseph Firth9,10, Davy Vancampfort1,2.
Abstract
BACKGROUND: It is currently unknown whether exergaming is efficacious in people with major neurocognitive disorder (MNCD) residing in long-term care facilities. This pilot randomized controlled trial (RCT) explored the efficacy of a stepping exergame program on gait speed, balance, mobility, reaction time, cognitive and neuropsychiatric outcomes, quality of life, and daily life functioning in people with MNCD residing in long-term care facilities.Entities:
Keywords: Brain plasticity; Cognition; Dementia; Depression; Physical activity; Physical fitness; Serious exergames
Year: 2021 PMID: 33785077 PMCID: PMC8008333 DOI: 10.1186/s13195-021-00806-7
Source DB: PubMed Journal: Alzheimers Res Ther Impact factor: 6.982
Fig. 1Dividat Senso exergame device. Permission was obtained from the copyright holder. Picture from the website dividat.com
Fig. 2CONSORT diagram of participant flow
Participant characteristics
| Variables | Sub-category | Exergame group ( | Music group ( | |
|---|---|---|---|---|
| Age in years, mean (SD) | 84.7 (5.6) | 85.3 (6.5) | 0.224 | |
| Gender, | Male | 5 (21.7) | 5 (22.7) | > 0.999 |
| Female | 18 (78.3) | 17 (77.3) | > 0.999 | |
| MMSE, mean (SD)b | 18 (4.4) | 17 (4.2) | 0.102 | |
| Diagnosis, | Alzheimer’s disease | 17 (73.9) | 14 (63.6) | 0.530 |
| Vascular dementia | 2 (8.7) | 4 (18.2) | 0.414 | |
| Mixed Alzheimer’s and vascular dementia | 2 (8.7) | 3 (13.6) | 0.665 | |
| Frontotemporal Degeneration | 0 (0) | 1 (4.5) | 0.489 | |
| Lewy body disease | 0 (0) | 0 (0) | > 0.999 | |
| Neurocognitive disorder not otherwise specified | 2 (8.7) | 0 (0) | 0.489 | |
| Somatic comorbidities, | Diabetes type II | 2 (8.7) | 5 (22.7) | 0.243 |
| Heart disease | 8 (34.8) | 11 (50.0) | 0.375 | |
| Hypertension | 4 (17.4) | 0 (0) | 0.109 | |
| Gait disorders | 12 (52.2) | 14 (63.6) | 0.550 | |
| Visual deficiencies (cataract, glaucoma) | 3 (13.0) | 0 (0) | 0.233 | |
| Indoor mobility, | Wheelchair | 2 (8.7) | 0 (0) | 0.49 |
| 4-wheeled walker | 3 (13.0) | 4 (18.2) | 0.70 | |
| Single-point walking cane | 0 (0) | 2 (9.1) | 0.23 | |
| No walking aid | 18 (78.3) | 16 (72.7) | 0.74 | |
| Attendance rates (%) | 82.9 | 73.7 | 0.07 |
ap values of group comparisons refer to Mann-Whitney U tests for continuous variables and Fisher’s exact tests for categorical variables
bScores on the MMSE range from 0 (severe impairment) to 30 (no impairment)
MMSE Mini-Mental State Examination
The effects of an exergame intervention and a music intervention on measured outcomes
| Variable | Intervention ( | Control ( | |||||
|---|---|---|---|---|---|---|---|
| Pre test (mean ± SD) | Post test (mean ± SD) | Pre test (mean ± SD) | Post test (mean ± SD) | ||||
| SPPB | 5.5 ± 1.9 | 8.5 ± 2.5 | 5.2 ± 2.9 | 3.8 ± 2.5 | < 0.001* | 72.1 | 0.64 |
| Gait speed (m/s) | 0.6 ± 0.2 | 0.8 ± 0.3 | 0.6 ± 0.2 | 0.5 ± 0.2 | < 0.001* | 29.3 | 0.41 |
| SRTT (ms) | 2827.1 ± 1884.1 | 1426.6 ± 333.1 | 4551.1 ± 4243.6 | 5292.9 ± 4893.4 | < 0.001* | 38.8 | 0.51 |
| MoCA | 9.4 ± 4.1 | 12.1 ± 5.2 | 8.5 ± 5.2 | 5.7 ± 4.0 | < 0.001* | 24.4 | 0.38 |
| NPI | 11.4 ± 12.8 | 6.6 ± 11.4 | 8.4 ± 7.4 | 16.1 ± 15.1 | 0.165 | 2.0 | 0.05 |
| CSDD | 7.0 ± 6.4 | 3.0 ± 4.4 | 5.3 ± 4.5 | 9.3 ± 6.7 | < 0.001* | 28.8 | 0.43 |
| DQoL | 2.7 ± 0.7 | 3.5 ± 0.9 | 3.0 ± 0.9 | 3.0 ± 0.9 | 0.012 | 6.9 | 0.16 |
| ADL | 9.0 ± 2.1 | 9.0 ± 2.3 | 10.1 ± 2.8 | 11.4 ± 3.4 | 0.008 | 7.7 | 0.16 |
*Significant when P < 0.00625 (0.05/8 comparisons) using Quade’s non-parametric analyses of covariance with post test scores as dependent variables, groups as independent variables, and baseline scores as covariates. ADL, activities of daily living (range = 6 to 24 with higher scores indicating higher dependency in activities of daily living); CSDD, Cornell scale for depression in dementia (range = 0 to 38, and a score below 6 is associated with absence of depressive symptoms, and scores above 10 indicate probable major depression); DQoL, Dementia Quality of Life (scores range from 1 (poor QoL) to 5 (excellent QoL)); MoCA, Montréal Cognitive Assessment (total scores range from 0 to 30 with lower scores indicating more cognitive impairment); NPI, Neuropsychiatric Inventory (12-item score with a range of 0 to 12 per item); SPPB, Short Physical Performance Battery (total scores range from 0 to 12 with lower scores indicating a higher risk and a score lower than 10 indicates one or more mobility limitations); SRTT, step reaction time test (lower values indicate a faster reaction time)